<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33882964</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>21</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>A hSCARB2-transgenic mouse model for Coxsackievirus A16 pathogenesis.</ArticleTitle><Pagination><StartPage>84</StartPage><MedlinePgn>84</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">84</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-021-01557-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus.</AbstractText><AbstractText Label="METHODS">Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection.</AbstractText><AbstractText Label="RESULTS">Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1&#x3b2;, IL-6, IL-18, and IFN-&#x3b3; in nasal mucosa, lungs and brain tissues.</AbstractText><AbstractText Label="CONCLUSIONS">The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yanli</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Yunnan Key Laboratory of Vaccine Research and Development On Severe Infectious Diseases, Chinese Academy of Medical Science and Peking Union Medical College, No. 935 Alternating Current Road, Wuhua District, Kunming, 650118, Yunna, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Heng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Yunnan Key Laboratory of Vaccine Research and Development On Severe Infectious Diseases, Chinese Academy of Medical Science and Peking Union Medical College, No. 935 Alternating Current Road, Wuhua District, Kunming, 650118, Yunna, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jinxi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Yunnan Key Laboratory of Vaccine Research and Development On Severe Infectious Diseases, Chinese Academy of Medical Science and Peking Union Medical College, No. 935 Alternating Current Road, Wuhua District, Kunming, 650118, Yunna, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Huiwen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Yunnan Key Laboratory of Vaccine Research and Development On Severe Infectious Diseases, Chinese Academy of Medical Science and Peking Union Medical College, No. 935 Alternating Current Road, Wuhua District, Kunming, 650118, Yunna, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Yunnan Key Laboratory of Vaccine Research and Development On Severe Infectious Diseases, Chinese Academy of Medical Science and Peking Union Medical College, No. 935 Alternating Current Road, Wuhua District, Kunming, 650118, Yunna, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Weiyu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Yunnan Key Laboratory of Vaccine Research and Development On Severe Infectious Diseases, Chinese Academy of Medical Science and Peking Union Medical College, No. 935 Alternating Current Road, Wuhua District, Kunming, 650118, Yunna, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zening</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Yunnan Key Laboratory of Vaccine Research and Development On Severe Infectious Diseases, Chinese Academy of Medical Science and Peking Union Medical College, No. 935 Alternating Current Road, Wuhua District, Kunming, 650118, Yunna, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Yunnan Key Laboratory of Vaccine Research and Development On Severe Infectious Diseases, Chinese Academy of Medical Science and Peking Union Medical College, No. 935 Alternating Current Road, Wuhua District, Kunming, 650118, Yunna, China. songjie@imbcams.com.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China. songjie@imbcams.com.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Longding</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8335-5613</Identifier><AffiliationInfo><Affiliation>Institute of Medical Biology, Yunnan Key Laboratory of Vaccine Research and Development On Severe Infectious Diseases, Chinese Academy of Medical Science and Peking Union Medical College, No. 935 Alternating Current Road, Wuhua District, Kunming, 650118, Yunna, China. longdingl@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China. longdingl@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus A16 (CA16)</Keyword><Keyword MajorTopicYN="N">Foot and mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">Hand</Keyword><Keyword MajorTopicYN="N">Human scavenger receptor class B</Keyword><Keyword MajorTopicYN="N">Respiratory and neurological pathology</Keyword><Keyword MajorTopicYN="N">member 2 (hSCARB2)</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33882964</ArticleId><ArticleId IdType="pmc">PMC8061046</ArticleId><ArticleId IdType="doi">10.1186/s12985-021-01557-5</ArticleId><ArticleId IdType="pii">10.1186/s12985-021-01557-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Koh WM, Bogich T, Siegel K, Jin J, Chong EY, Tan CY, Chen MI, Horby P, Cook AR: The epidemiology of hand, foot and mouth disease in Asia: a systematic review and analysis. Pediatr Infect Dis J. 2016, 35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5130063</ArticleId><ArticleId IdType="pubmed">27273688</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang C-Y, Liu C-C. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease. Expert Rev Vaccines. 2018;17:819&#x2013;831. doi: 10.1080/14760584.2018.1510326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2018.1510326</ArticleId><ArticleId IdType="pubmed">30095317</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaf H, Pelosi E, Cooper A, Pappachan J, Sykes K, MacIntosh I, Gbesemete D, Clark TW, Patel SV, Faust SN. Severe enterovirus infections in hospitalized children in the South of England: clinical phenotypes and causative genotypes. Pediatr Infect Dis J. 2016;35:723. doi: 10.1097/INF.0000000000001093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001093</ArticleId><ArticleId IdType="pmc">PMC4985250</ArticleId><ArticleId IdType="pubmed">26882165</ArticleId></ArticleIdList></Reference><Reference><Citation>Owatanapanich S, Wutthanarungsan R, Jaksupa W, Thisyakorn U. Risk factors for severe enteroviral infections in children. J Med Assoc Thai. 2016;99:322&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pubmed">27276744</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Zhang H, Liu H, Zhang J, He L, Sun H, Huang X, Yang Z, Ma S: Molecular characteristics of hand, foot, and mouth disease for hospitalized pediatric patients in Yunnan, China. Medicine 2018, 97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6081097</ArticleId><ArticleId IdType="pubmed">30075535</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B-S, Lee H-C, Lee K-M, Gong Y-N, Shih S-R. Enterovirus and Encephalitis. Front Microbiol. 2020;11:261&#x2013;261. doi: 10.3389/fmicb.2020.00261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00261</ArticleId><ArticleId IdType="pmc">PMC7044131</ArticleId><ArticleId IdType="pubmed">32153545</ArticleId></ArticleIdList></Reference><Reference><Citation>Majer A, McGreevy A, Booth TF. Molecular pathogenicity of enteroviruses causing neurological disease. Front Microbiol. 2020;11:540&#x2013;540. doi: 10.3389/fmicb.2020.00540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00540</ArticleId><ArticleId IdType="pmc">PMC7161091</ArticleId><ArticleId IdType="pubmed">32328043</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehlenbachs A, Bhatnagar J, Zaki SR. Tissue tropism, pathology and pathogenesis of enterovirus infection. J Pathol. 2015;235:217&#x2013;228. doi: 10.1002/path.4438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4438</ArticleId><ArticleId IdType="pubmed">25211036</ArticleId></ArticleIdList></Reference><Reference><Citation>Phyu WK, Ong KC, Wong KT. Modelling person-to-person transmission in an Enterovirus A71 orally infected hamster model of hand-foot-and-mouth disease and encephalomyelitis. Emerg Microbes Infect. 2017;6:1&#x2013;9. doi: 10.1038/emi.2017.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2017.49</ArticleId><ArticleId IdType="pmc">PMC5567166</ArticleId><ArticleId IdType="pubmed">28698666</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Lin H, Lin J, He J, Deng A, Kang M, Zeng H, Ma W, Zhang Y. Evaluating the transmission routes of hand, foot, and mouth disease in Guangdong China. Am J Infect Control. 2016;44:e13&#x2013;e14. doi: 10.1016/j.ajic.2015.04.202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2015.04.202</ArticleId><ArticleId IdType="pubmed">26803935</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaoutis T, Klein JD. Enterovirus infections. Pediatrics Rev. 1998;19:183&#x2013;191. doi: 10.1542/pir.19-6-183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/pir.19-6-183</ArticleId><ArticleId IdType="pubmed">9613170</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Shi J, Huang X, Liu F, Cai Y, Lan K, Huang Z. A murine model of coxsackievirus A16 infection for anti-viral evaluation. Antiviral Res. 2014;105:26&#x2013;31. doi: 10.1016/j.antiviral.2014.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.02.015</ArticleId><ArticleId IdType="pubmed">24583030</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine EA, Fuchs J, Das SC, Partidos CD, Osorio JE. Efficacy of a trivalent hand, foot, and mouth disease vaccine against enterovirus 71 and coxsackieviruses A16 and A6 in mice. Viruses. 2015;7:5919&#x2013;5932. doi: 10.3390/v7112916.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7112916</ArticleId><ArticleId IdType="pmc">PMC4664989</ArticleId><ArticleId IdType="pubmed">26593938</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao P, Miao Z, Xu F, Lu H, Sun Y, Xia Y, Chen C, Yang Z, Xia S, Jiang J. An adult gerbil model for evaluating potential coxsackievirus A16 vaccine candidates. Vaccine. 2019;37:5341&#x2013;5349. doi: 10.1016/j.vaccine.2019.07.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.07.046</ArticleId><ArticleId IdType="pubmed">31351798</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Gao R, Shao J, Yao X, Lang S, Wang C, Mao P, Liang Z, Wang J. A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol. 2012;86:11967&#x2013;11976. doi: 10.1128/JVI.00902-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00902-12</ArticleId><ArticleId IdType="pmc">PMC3486452</ArticleId><ArticleId IdType="pubmed">22951825</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Li Y, Xia Y, Xu F, Wang W, Yang Z, Lu H, Chen Z, Miao Z, Liang W. Coxsackievirus A16 induced neurological disorders in young gerbils which could serve as a new animal model for vaccine evaluation. Sci Rep. 2016;6:34299&#x2013;34299. doi: 10.1038/srep34299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34299</ArticleId><ArticleId IdType="pmc">PMC5035925</ArticleId><ArticleId IdType="pubmed">27667023</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooi YT, Ong KC, Tan SH, Perera D, Wong KT. A novel orally infected hamster model for Coxsackievirus A16 hand-foot-and-mouth disease and encephalomyelitis. Lab Invest. 2020;100:1262&#x2013;1275. doi: 10.1038/s41374-020-0456-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41374-020-0456-x</ArticleId><ArticleId IdType="pubmed">32601355</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian-Ping L, Yun L. Experimental infection of tree shrews (Tupaia belangeri) with Coxsackie virus A16. Zool Res. 2014;35:485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4790277</ArticleId><ArticleId IdType="pubmed">25465084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zhang Y, Zhang X, Hu Y, Dong C, Liu L, Yang E, Che Y, Pu J, Wang X. Pathologic and immunologic characteristics of coxsackievirus A16 infection in rhesus macaques. Virology. 2017;500:198&#x2013;208. doi: 10.1016/j.virol.2016.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.10.031</ArticleId><ArticleId IdType="pubmed">27829175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Koike S. Cellular receptors for enterovirus A71. J Biomed Sci. 2020;27:23&#x2013;23. doi: 10.1186/s12929-020-0615-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, Nishimura H, Sanjoh K, Katsushima N, Itagaki T. Human SCARB2-Dependent Infection by Coxsackievirus A7, A14, and A16 and Enterovirus 71. J Virol. 2012;86:5686&#x2013;5696. doi: 10.1128/JVI.00020-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00020-12</ArticleId><ArticleId IdType="pmc">PMC3347270</ArticleId><ArticleId IdType="pubmed">22438546</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15:798&#x2013;801. doi: 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Fan P, Jin J, Su W, An D, Xu L, Sun S, Zhang Y, Meng X, Gao F, et al. Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virol J. 2013;10:250. doi: 10.1186/1743-422X-10-250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-250</ArticleId><ArticleId IdType="pmc">PMC3765843</ArticleId><ArticleId IdType="pubmed">23919614</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol. 2013;87:3335&#x2013;3347. doi: 10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Koike S. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol. 2011;85:4937&#x2013;4946. doi: 10.1128/JVI.02358-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02358-10</ArticleId><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuronita T, Eskelinen EL, Fujita H, Saftig P, Himeno M, Tanaka Y. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J Cell Sci. 2002;115:4117&#x2013;4131. doi: 10.1242/jcs.00075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.00075</ArticleId><ArticleId IdType="pubmed">12356916</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskelinen EL, Tanaka Y, Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003;13:137&#x2013;145. doi: 10.1016/S0962-8924(03)00005-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(03)00005-9</ArticleId><ArticleId IdType="pubmed">12628346</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamp AC, Tanaka Y, L&#xfc;llmann-Rauch R, Wittke D, D'Hooge R, De Deyn PP, Moser T, Maier H, Hartmann D, Reiss K, et al. LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. Hum Mol Genet. 2003;12:631&#x2013;646. doi: 10.1093/hmg/ddg062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddg062</ArticleId><ArticleId IdType="pubmed">12620969</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-W, Yu S-L, Shao H-Y, Lin H-Y, Liu C-C, Hsiao K-N, Chitra E, Tsou Y-L, Chang H-W, Sia C, et al. Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS ONE. 2013;8:e57591. doi: 10.1371/journal.pone.0057591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057591</ArticleId><ArticleId IdType="pmc">PMC3581494</ArticleId><ArticleId IdType="pubmed">23451246</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Nagata N, Sato Y, Ong KC, Wong KT, Yamayoshi S, Shimanuki M, Shitara H, Taya C, Koike S. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci USA. 2013;110:14753&#x2013;14758. doi: 10.1073/pnas.1217563110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou AT, Wu SY, Liao CC, Chang YS, Chang CS, Shih C. A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71. Sci Rep. 2016;6:31151. doi: 10.1038/srep31151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31151</ArticleId><ArticleId IdType="pmc">PMC4976353</ArticleId><ArticleId IdType="pubmed">27499235</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Liu Q, Wu X, Chen P, Wu X, Guo Y, Liu S, Liang Z, Fan C, Wang Y. A safe and sensitive enterovirus A71 infection model based on human SCARB2 knock-in mice. Vaccine. 2016;34:2729&#x2013;2736. doi: 10.1016/j.vaccine.2016.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.04.029</ArticleId><ArticleId IdType="pubmed">27102822</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Kanneganti T-D. Cutting edge: distinct regulatory mechanisms control proinflammatory cytokines IL-18 and IL-1&#x3b2;. J Immunol. 2017;198:4210&#x2013;4215. doi: 10.4049/jimmunol.1700352.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700352</ArticleId><ArticleId IdType="pmc">PMC5544497</ArticleId><ArticleId IdType="pubmed">28468974</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C, Liao C, Liou A, Chang Y, Chang Y, Tzeng B, Chen C, Shih C. Enterovirus 71 targets the cardiopulmonary system in a robust oral infection mouse model. Sci Rep. 2019;9:11108. doi: 10.1038/s41598-019-47455-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-47455-3</ArticleId><ArticleId IdType="pmc">PMC6668393</ArticleId><ArticleId IdType="pubmed">31366973</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2&#x2c6;(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013;3:71&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4280562</ArticleId><ArticleId IdType="pubmed">25558171</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M, Liang Z. Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother. 2014;10:360&#x2013;367. doi: 10.4161/hv.27087.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.27087</ArticleId><ArticleId IdType="pmc">PMC4185891</ArticleId><ArticleId IdType="pubmed">24231751</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin D-q, Wang C-b, Wang C-b. Epidemiology characteristics of human coxsackievirus a16 and enterovirus 71 circulating in Linyi, China, from 2009 to 2017. Jpn J Infect Dis. 2018;71:470&#x2013;473. doi: 10.7883/yoken.JJID.2018.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.JJID.2018.035</ArticleId><ArticleId IdType="pubmed">29962487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Huang Z, Huang M, Zeng J. Predicting Severe Enterovirus 71-Infected Hand, Foot, and Mouth Disease: Cytokines and Chemokines. Mediators Inflamm. 2020;2020:9273241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7013319</ArticleId><ArticleId IdType="pubmed">32089650</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Li S, Cai C, Liu J, Wang Y, Jiang Y, Du L, Chen Z. Characterization of inflammatory cytokine profiles in cerebrospinal fluid of hand, foot, and mouth disease children with enterovirus 71-related encephalitis in Hangzhou, Zhejiang, China. Medicine (Baltimore) 2019;98:e18464. doi: 10.1097/MD.0000000000018464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000018464</ArticleId><ArticleId IdType="pmc">PMC6946215</ArticleId><ArticleId IdType="pubmed">31876729</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye N, Gong X. Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections. BMC Infect Dis. 2015;15:225&#x2013;225. doi: 10.1186/s12879-015-0965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-015-0965-1</ArticleId><ArticleId IdType="pmc">PMC4461975</ArticleId><ArticleId IdType="pubmed">26058678</ArticleId></ArticleIdList></Reference><Reference><Citation>Food DA. H: New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible final rule. Fed Reg. 2002;67:37988.</Citation><ArticleIdList><ArticleId IdType="pubmed">12049094</ArticleId></ArticleIdList></Reference><Reference><Citation>Park GD, Mitchel JT. Working with the US Food and Drug Administration to obtain approval of products under the animal rule. Ann N Y Acad Sci. 2016;1374:10&#x2013;16. doi: 10.1111/nyas.13126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.13126</ArticleId><ArticleId IdType="pubmed">27336401</ArticleId></ArticleIdList></Reference><Reference><Citation>Safronetz D, Geisbert TW, Feldmann H. Animal models for highly pathogenic emerging viruses. Curr Opin Virol. 2013;3:205&#x2013;209. doi: 10.1016/j.coviro.2013.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2013.01.001</ArticleId><ArticleId IdType="pmc">PMC3644300</ArticleId><ArticleId IdType="pubmed">23403208</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Zhang B, Feng Y, Xu C, Jiang J, Lu Y. Establishment and characterization of an oral gerbil model for a non-mouse-adapted enterovirus 71 strain. Virus Res. 2018;255:117&#x2013;126. doi: 10.1016/j.virusres.2018.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2018.07.008</ArticleId><ArticleId IdType="pubmed">30030018</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Yan B, Yeo H, Tan EL, Lee JJ, Ng JK, Chow VT, Alonso S. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol. 2012;86:2121&#x2013;2131. doi: 10.1128/JVI.06103-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu D, Zhao XY, Yao Y, Dai FF, He H, Li RQ, Jin RH, Liang LC, Li N. A new factor influencing pathogen detection by molecular assay in children with both mild and severe hand, foot, and mouth disease. Diagn Microbiol Infect Dis. 2013;76:162&#x2013;167. doi: 10.1016/j.diagmicrobio.2013.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2013.02.011</ArticleId><ArticleId IdType="pmc">PMC7126308</ArticleId><ArticleId IdType="pubmed">23535205</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao CC, Liou AT, Chang YS, Wu SY, Chang CS, Lee CK, Kung JT, Tu PH, Yu YY, Lin CY, et al. Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71. J Virol. 2014;88:12485&#x2013;12499. doi: 10.1128/JVI.00692-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00692-14</ArticleId><ArticleId IdType="pmc">PMC4248922</ArticleId><ArticleId IdType="pubmed">25142603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuss SK, Etheredge CA, Pfeiffer JK. Multiple host barriers restrict poliovirus trafficking in mice. PLoS Pathog. 2008;4:e1000082. doi: 10.1371/journal.ppat.1000082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000082</ArticleId><ArticleId IdType="pmc">PMC2390757</ArticleId><ArticleId IdType="pubmed">18535656</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>